_GoBack - 57th Annual Meeting of the JSGE - Hajime Takikawa, MD, PhD

ewgn-vol20-issue4-FINAL

37 WORLD GASTROENTEROLOGY NEWS JANUARY 2016 Gastro 2015: AGW-WGO | Expert Point of View | Gastro 2016: EGHS-WGO | WDHD News | WGO & WGOF News | WGO Global Guidelines | Calendar of Events 57th Annual Meeting of the JSGE Hajime Takikawa, MD, PhD Dean Professor and Chairman, Department of Medicine Teikyo University School of Medicine President of the 57th Annual Meeting of the Japanese Society of Gastroenterology (JSGE) Tokyo, Japan The 57th Annual Meeting of the Japanese Society of Gastroenterol-ogy (JSGE) was held at the Grand Prince Hotel New Takanawa and Grand Prince Hotel Takanawa in Tokyo, Japan, for two and a half days from 8-10 October 2015, as part of Japan Digestive Disease Week 2015 (JDDW 2015). Starting in 2015, the number of themes was reduced because the regu-lar annual meeting was conducted over three days, with the fourth day reserved exclusively for educational presentations. Special lectures were “Pretargeting antibody drug for diagnosis and treat-ment of advance colon cancer” by Professor Tatsuhiko Kodama (Depart-ment of Systems Biology and Medi-cine, Research Center for Advanced Science and Technology, The Univer-sity of Tokyo) and “The gastronomic meal of the French” by Professor Isao Hirota (Teikyo University, Faculty of Economics). Two English sessions were orga-nized: “Recent progress in IgG4-relat-ed pancreatobiliary diseases,” chaired by Professor Kazuichi Okazaki (Department of Gastroenterology and Hepatology, Kansai Medical Uni-versity) and Professor Suresh Chari (Mayo Clinic), and “Recent progres-sion in drug-induced liver injury (DILI),” chaired by Professor Yasushi Matsuzaki (Tokyo Medical University Ibaraki Medical Center) and Professor Neil Kaplowitz (USC Keck School of Medicine). The following sessions were organized by JSGE and presented in Japanese with English slides: two joint programs with gastroenterologi-cal surgery, “Intrahepatic and hilar cholangiocarcinomas: Classifica-tion and therapeutic strategy” and “Multidisciplinary approach for stage IV colorectal cancer”; three symposia, “New horizons for chronic hepatitis C treatment - Dawn of IFN-free era,” “Cooperation between internists and surgeons in the treatment of inflam-matory bowel disease,” and “Issues after H. pylori eradication and the search for their solutions”; three panel discussions, “Current status of chemo-radiotherapy for esophageal cancer,” “Therapeutic strategy for acute liver failure: Medical liaison between hepa-tologists and transplant surgeons,” and “Progress of the chemotherapies for pancreato-biliary carcinomas: Neoadjuvant and adjuvant che-motherapies, and chemotherapies for unresectable cases”; and seven workshops, “Diagnosis and treatment of Gastrointestinal neuroectodermal tumor (gNET),” “Pathophysiological significance of intestinal microbiota in digestive disorders,” “Recent progress in functional upper gastrointestinal disorder,” “Intraductal papillary-mucinous neoplasm versus intraductal Speech by Prof. Takikawa at welcome recep-tion. papillary neoplasm of the bile duct,” “Current condition and future trend of clinical metabolomics,” “Bile acids in digestive diseases: Relation to pathophysiology, diagnosis, and therapeutics,” and “Recent progress in autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC).” A medical staff program was started this year: “Providing better medical cares for patients: Roles of medical staffs with special reference to ad-vanced practice nurse system,” chaired by Dr. Kentaro Sugano (President, Organization of Japan Digestive Dis-ease Week) and Ms. Kiyoko Okubo (Vice President, Japanese Nursing Association). Poster sessions (501 posters) were presented in Japanese by digital post-ers. In addition, several posters were presented in English as International Poster Sessions. Members of Gastroenterology Division, Department of Medicine, Teikyo University School of Medicine.


ewgn-vol20-issue4-FINAL
To see the actual publication please follow the link above